Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.120 | 18 | 63126688 | 3 prime UTR variant | T/C | snv | 5.1E-02 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.800 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.120 | 18 | 63126316 | 3 prime UTR variant | C/T | snv | 5.9E-02 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.800 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.120 | 18 | 63178651 | intron variant | T/A;C | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||
|
0.925 | 0.120 | 18 | 63178651 | intron variant | T/A;C | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
0.925 | 0.120 | 18 | 63178651 | intron variant | T/A;C | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||
|
0.925 | 0.120 | 18 | 63178651 | intron variant | T/A;C | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
18 | 63253621 | intron variant | C/T | snv | 2.1E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
18 | 63253621 | intron variant | C/T | snv | 2.1E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
18 | 63253621 | intron variant | C/T | snv | 2.1E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
18 | 63253621 | intron variant | C/T | snv | 2.1E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
18 | 63253621 | intron variant | C/T | snv | 2.1E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
18 | 63253621 | intron variant | C/T | snv | 2.1E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
18 | 63253621 | intron variant | C/T | snv | 2.1E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
18 | 63213468 | intron variant | T/C | snv | 4.1E-03 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
0.925 | 0.120 | 18 | 63126688 | 3 prime UTR variant | T/C | snv | 5.1E-02 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.120 | 18 | 63126316 | 3 prime UTR variant | C/T | snv | 5.9E-02 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.120 | 18 | 63126261 | 3 prime UTR variant | C/T | snv | 6.0E-02 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
18 | 63123839 | 3 prime UTR variant | C/T | snv | 6.4E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
18 | 63123839 | 3 prime UTR variant | C/T | snv | 6.4E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
18 | 63123839 | 3 prime UTR variant | C/T | snv | 6.4E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 0.080 | 18 | 63293961 | intron variant | TT/-;T;TTT;TTTT;TTTTT;TTTTTTTTTTTT;TTTTTTTTTTTTTTT | delins |
|
Neoplasms; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.925 | 0.120 | 18 | 63257737 | intron variant | C/T | snv | 0.42 |
|
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.120 | 18 | 63257737 | intron variant | C/T | snv | 0.42 |
|
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
18 | 63167937 | intron variant | A/G;T | snv | 0.29 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
0.925 | 0.120 | 18 | 63178651 | intron variant | T/A;C | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 |